Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Cold Spring Harb Perspect Biol
2013 Feb 01;52:. doi: 10.1101/cshperspect.a008011.
Show Gene links
Show Anatomy links
Wnt signaling in normal and malignant hematopoiesis.
Lento W
,
Congdon K
,
Voermans C
,
Kritzik M
,
Reya T
.
???displayArticle.abstract???
One of the most remarkable characteristics of stem cells is their ability to perpetuate themselves through self-renewal while concomitantly generating differentiated cells. In the hematopoietic system, stem cells balance these mechanisms to maintain steady-state hematopoiesis for the lifetime of the organism, and to effectively regenerate the system following injury. Defects in the proper control of self-renewal and differentiation can be potentially devastating and contribute to the development of malignancies. In this review, we trace the emerging role of Wnt signaling as a critical regulator of distinct aspects of self-renewal and differentiation, its contribution to the maintenance of homeostasis and regeneration, and how the pathway can be hijacked to promote leukemia development. A better understanding of these processes could pave the way to enhancing recovery after injury and to developing better therapeutic approaches for hematologic malignancies.
Abrahamsson,
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
2009,
Pubmed
Austin,
A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells.
1997,
Pubmed
Baba,
Constitutively active beta-catenin promotes expansion of multipotent hematopoietic progenitors in culture.
2006,
Pubmed
Baba,
Constitutively active beta-catenin confers multilineage differentiation potential on lymphoid and myeloid progenitors.
2005,
Pubmed
Baldridge,
Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection.
2010,
Pubmed
Cheng,
Numb mediates the interaction between Wnt and Notch to modulate primitive erythropoietic specification from the hemangioblast.
2008,
Pubmed
Clements,
A somitic Wnt16/Notch pathway specifies haematopoietic stem cells.
2011,
Pubmed
Congdon,
Activation of Wnt signaling in hematopoietic regeneration.
2008,
Pubmed
Corrigan,
Patterns of Wnt/Fzd/LRP gene expression during embryonic hematopoiesis.
2009,
Pubmed
Dufourcq,
Secreted frizzled-related protein-1 enhances mesenchymal stem cell function in angiogenesis and contributes to neovessel maturation.
2008,
Pubmed
Durand,
Newly emerging roles for prostaglandin E2 regulation of hematopoiesis and hematopoietic stem cell engraftment.
2010,
Pubmed
Gattinoni,
Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapy.
2010,
Pubmed
Goessling,
Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration.
2009,
Pubmed
Gregory,
Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl.
2010,
Pubmed
Guo,
Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation.
2008,
Pubmed
Guo,
Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation.
2007,
Pubmed
Hoggatt,
Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation.
2009,
Pubmed
Huang,
Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice.
2009,
Pubmed
Ioannidis,
The beta-catenin--TCF-1 pathway ensures CD4(+)CD8(+) thymocyte survival.
2001,
Pubmed
Jamieson,
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.
2004,
Pubmed
Kirstetter,
Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block.
2006,
Pubmed
Ko,
GSK-3β inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expression.
2011,
Pubmed
Li,
Role of neural-cadherin in early osteoblastic differentiation of human bone marrow stromal cells cocultured with human umbilical vein endothelial cells.
2010,
Pubmed
Liang,
Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue.
2003,
Pubmed
Liang,
Noncanonical Wnt signaling promotes apoptosis in thymocyte development.
2007,
Pubmed
Luis,
Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion.
2011,
Pubmed
Luis,
Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation.
2009,
Pubmed
Malhotra,
Contrasting responses of lymphoid progenitors to canonical and noncanonical Wnt signals.
2008,
Pubmed
Mazieres,
Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis.
2005,
Pubmed
McWhirter,
Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia.
1999,
Pubmed
Medvinsky,
Embryonic origin of the adult hematopoietic system: advances and questions.
2011,
Pubmed
Molenaar,
XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos.
1996,
Pubmed
,
Xenbase
Mulroy,
Wnt-1 and Wnt-4 regulate thymic cellularity.
2002,
Pubmed
Mulroy,
beta-Catenin expression enhances generation of mature thymocytes.
2003,
Pubmed
Müller-Tidow,
Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.
2004,
Pubmed
Nemeth,
Wnt5a inhibits canonical Wnt signaling in hematopoietic stem cells and enhances repopulation.
2007,
Pubmed
North,
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis.
2007,
Pubmed
Notani,
Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner.
2010,
Pubmed
Nusse,
WNT targets. Repression and activation.
1999,
Pubmed
,
Xenbase
Oosterwegel,
Cloning of murine TCF-1, a T cell-specific transcription factor interacting with functional motifs in the CD3-epsilon and T cell receptor alpha enhancers.
1991,
Pubmed
Perry,
Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion.
2011,
Pubmed
Planutiene,
Lymphoid enhancer-binding factor 1, a representative of vertebrate-specific Lef1/Tcf1 sub-family, is a Wnt-beta-catenin pathway target gene in human endothelial cells which regulates matrix metalloproteinase-2 expression and promotes endothelial cell invasion.
2011,
Pubmed
Qiu,
Activation of non-canonical Wnt/JNK pathway by Wnt3a is associated with differentiation fate determination of human bone marrow stromal (mesenchymal) stem cells.
2011,
Pubmed
Ranheim,
Frizzled 9 knock-out mice have abnormal B-cell development.
2005,
Pubmed
Reya,
A role for Wnt signalling in self-renewal of haematopoietic stem cells.
2003,
Pubmed
Reya,
Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism.
2000,
Pubmed
Scheller,
Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation.
2006,
Pubmed
Schilham,
Critical involvement of Tcf-1 in expansion of thymocytes.
1998,
Pubmed
Spencer,
Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.
2006,
Pubmed
Staal,
WNT signalling and haematopoiesis: a WNT-WNT situation.
2005,
Pubmed
Staal,
Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription.
2001,
Pubmed
Steele,
Canonical Wnt signaling negatively regulates platelet function.
2009,
Pubmed
Topol,
Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation.
2003,
Pubmed
Tran,
Wnt/beta-catenin signaling is involved in the induction and maintenance of primitive hematopoiesis in the vertebrate embryo.
2010,
Pubmed
,
Xenbase
Travis,
LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected].
1991,
Pubmed
Trowbridge,
Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation.
2006,
Pubmed
Van Den Berg,
Role of members of the Wnt gene family in human hematopoiesis.
1998,
Pubmed
Vijayaragavan,
Noncanonical Wnt signaling orchestrates early developmental events toward hematopoietic cell fate from human embryonic stem cells.
2009,
Pubmed
Wagner,
Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis.
2004,
Pubmed
Wang,
Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy.
2008,
Pubmed
Wang,
The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML.
2010,
Pubmed
Weerkamp,
Wnt signaling in the thymus is regulated by differential expression of intracellular signaling molecules.
2006,
Pubmed
Xu,
Beta-catenin expression results in p53-independent DNA damage and oncogene-induced senescence in prelymphomagenic thymocytes in vivo.
2008,
Pubmed
Xu,
Deletion of beta-catenin impairs T cell development.
2003,
Pubmed
Yeung,
β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells.
2010,
Pubmed
Yu,
T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma.
2009,
Pubmed
Zhao,
Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo.
2007,
Pubmed
Zheng,
Gamma-catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells.
2004,
Pubmed
van Genderen,
Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice.
1994,
Pubmed